Gestational exposure to antidepressants and the risk of spontaneous abortion: a review.

  title={Gestational exposure to antidepressants and the risk of spontaneous abortion: a review.},
  author={Perrine Broy and A. B{\'e}rard},
  journal={Current drug delivery},
  volume={7 1},
  • Perrine Broy, A. Bérard
  • Published 2010
  • Medicine
  • Current drug delivery
  • BACKGROUND Although the relationship between antidepressant use during pregnancy and its adverse effects has been widely investigated, very few studies have evaluated the impact of antidepressant use during pregnancy on the risk of spontaneous abortion. We present an overview of the evidence relating to the association between antidepressant use during gestation and the risk of spontaneous abortion. METHODS We systematically searched PubMed and the reference lists of all relevant articles… CONTINUE READING
    18 Citations
    Use of antidepressants during pregnancy and the risk of spontaneous abortion
    • 130
    • PDF
    Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence
    • 35
    Intimate relationships and childbearing after adolescent depression: a population-based 15 year follow-up study
    • 26


    Antidepressant Use during Pregnancy and the Rates of Spontaneous Abortions: A Meta-Analysis
    • 160
    Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database.
    • 67
    • Highly Influential
    Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials.
    • 119
    Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study.
    • 219
    • Highly Influential
    Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.
    • 185
    • Highly Influential
    Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes.
    • 129
    • Highly Influential
    Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects
    • 168
    • Highly Influential
    First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.
    • 262